000			01954 a2200577 4500
005			20250515051039.0
264		0	_c20070810
008			200708s 0 0 eng d
022			_a0923-7534
024	7		_a10.1093/annonc/mdl418 _2doi
040			_aNLM _beng _cNLM
100	1		_aSessa, C
245	0	0	_aConcerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMar 2007
300			_a561-8 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aEurope
650	0	4	_aFemale
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
700	1		_aCresta, S
700	1		_aCerny, T
700	1		_aBaselga, J
700	1		_aRota Caremoli, E
700	1		_aMalossi, A
700	1		_aHess, D
700	1		_aTrigo, J
700	1		_aZucchetti, M
700	1		_aD'Incalci, M
700	1		_aZaniboni, A
700	1		_aCapri, G
700	1		_aGatti, B
700	1		_aCarminati, P
700	1		_aZanna, C
700	1		_aMarsoni, S
700	1		_aGianni, L
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 18 _gno. 3 _gp. 561-8
856	4	0	_uhttps://doi.org/10.1093/annonc/mdl418 _zAvailable from publisher's website
999			_c16720395 _d16720395